Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
Review ArticleReview

Progress in oncolytic viruses modified with nanomaterials for intravenous application

Liting Chen, Zhijun Ma, Chen Xu, Youbang Xie, Defang Ouyang, Shuhui Song, Xiao Zhao and Funan Liu
Cancer Biology & Medicine November 2023, 20230275; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0275
Liting Chen
1Department of Surgical Oncology and General Surgery, Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, The First Affiliated Hospital of China Medical University, Shenyang 110001, China
2Phase I Clinical Trials Center, Ministry of Education, The First Affiliated Hospital of China Medical University, Shenyang 110102, China
3CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhijun Ma
4Department of General Surgery, Panjin People’s Hospital, Panjin 124221, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chen Xu
1Department of Surgical Oncology and General Surgery, Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, The First Affiliated Hospital of China Medical University, Shenyang 110001, China
2Phase I Clinical Trials Center, Ministry of Education, The First Affiliated Hospital of China Medical University, Shenyang 110102, China
3CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Youbang Xie
5Department of Hematology and Rheumatology, Qinghai Provincial People’s Hospital, Xining 810007, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Defang Ouyang
6State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences (ICMS), University of Macau, Macau 999078, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shuhui Song
1Department of Surgical Oncology and General Surgery, Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, The First Affiliated Hospital of China Medical University, Shenyang 110001, China
2Phase I Clinical Trials Center, Ministry of Education, The First Affiliated Hospital of China Medical University, Shenyang 110102, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiao Zhao
3CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China
7Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing 100049, China
8IGDB-NCNST Joint Research Center, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Xiao Zhao
  • For correspondence: zhaox{at}nanoctr.cn fnliu{at}cmu.edu.cn
Funan Liu
1Department of Surgical Oncology and General Surgery, Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, The First Affiliated Hospital of China Medical University, Shenyang 110001, China
2Phase I Clinical Trials Center, Ministry of Education, The First Affiliated Hospital of China Medical University, Shenyang 110102, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Funan Liu
  • For correspondence: zhaox{at}nanoctr.cn fnliu{at}cmu.edu.cn
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Information

20230275
DOI 
https://doi.org/10.20892/j.issn.2095-3941.2023.0275

Published By 
Cancer Biology & Medicine
History 
  • Received July 25, 2023
  • Accepted September 25, 2023
  • Published online November 24, 2023.

Article Versions

  • You are currently viewing a previous version of this article (November 24, 2023 - 03:42).
  • View the most recent version of this article
Copyright & Usage 
Copyright: © 2023, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Author Information

  1. Liting Chen1,2,3,*,
  2. Zhijun Ma4,*,
  3. Chen Xu1,2,3,
  4. Youbang Xie5,
  5. Defang Ouyang6,
  6. Shuhui Song1,2,
  7. Xiao Zhao3,7,8⇑ and
  8. Funan Liu1,2⇑
  1. 1Department of Surgical Oncology and General Surgery, Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, The First Affiliated Hospital of China Medical University, Shenyang 110001, China
  2. 2Phase I Clinical Trials Center, Ministry of Education, The First Affiliated Hospital of China Medical University, Shenyang 110102, China
  3. 3CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China
  4. 4Department of General Surgery, Panjin People’s Hospital, Panjin 124221, China
  5. 5Department of Hematology and Rheumatology, Qinghai Provincial People’s Hospital, Xining 810007, China
  6. 6State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences (ICMS), University of Macau, Macau 999078, China
  7. 7Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing 100049, China
  8. 8IGDB-NCNST Joint Research Center, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, China
  1. Correspondence to: Xiao Zhao and Funan Liu, E-mail: zhaox{at}nanoctr.cn and fnliu{at}cmu.edu.cn
View Full Text

Funding

  • National Key R&D Program of China

    2021YFA0909900, X. Z.
  • National Key R&D Program of China

    2022YFC2403401, F. L.
  • National Natural Science Foundation of China

    32222045
  • National Natural Science Foundation of China

    32171384, X. Z.
  • National Natural Science Foundation of China

    82073368, F. L.
  • Liaoning Revitalization Talents Program

    XLYC2007071, F. L.
  • Top-notch Talents Project of 2022 “Kunlun Yingcai Advanced Innovation and Entrepreneurship” in Qinghai Province (Y. X.)

This work was supported by grants from the National Key R&D Program of China (Grant Nos. 2021YFA0909900, X. Z.; 2022YFC2403401, F. L.), the National Natural Science Foundation of China (Grant Nos. 32222045 and 32171384, X. Z.; 82073368, F. L.), the Liaoning Revitalization Talents Program (Grant No. XLYC2007071, F. L.), and the Top-notch Talents Project of 2022 “Kunlun Yingcai Advanced Innovation and Entrepreneurship” in Qinghai Province (Y. X.).

Next
Back to top

In this issue

Cancer Biology & Medicine: 23 (3)
Cancer Biology & Medicine
Vol. 23, Issue 3
15 Mar 2026
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Progress in oncolytic viruses modified with nanomaterials for intravenous application
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
Progress in oncolytic viruses modified with nanomaterials for intravenous application
Liting Chen, Zhijun Ma, Chen Xu, Youbang Xie, Defang Ouyang, Shuhui Song, Xiao Zhao, Funan Liu
Cancer Biology & Medicine Nov 2023, 20230275; DOI: 10.20892/j.issn.2095-3941.2023.0275

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Progress in oncolytic viruses modified with nanomaterials for intravenous application
Liting Chen, Zhijun Ma, Chen Xu, Youbang Xie, Defang Ouyang, Shuhui Song, Xiao Zhao, Funan Liu
Cancer Biology & Medicine Nov 2023, 20230275; DOI: 10.20892/j.issn.2095-3941.2023.0275
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Liposomes
    • Polymers
    • Albumin
    • Other nanoparticles
    • Conclusions and future perspectives
    • Conflicts of interest statement
    • Author contributions
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • Improving systemic delivery of oncolytic virus by cellular carriers
  • Google Scholar

More in this TOC Section

  • Unravelling the role of PANoptosis in diseases: from emerging molecular mechanisms-to-therapeutic implications
  • The m7G RNA modification in gastrointestinal cancers: mechanisms and therapeutic potential
  • Pyroptosis in cancer: a dual regulator of tumor cell fate and immune activation
Show more Review

Similar Articles

Keywords

  • oncolytic virus
  • nanomaterials
  • drug delivery
  • tumor treatment
  • intravenous application

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire